GeneDx Q3 Results: 40% YoY Growth, $53M in Revenue, Stock Continues Decline
GeneDx Holdings Corp, a leading provider of enhanced health insights through genomic and clinical expertise, unveiled its revenue results for the third quarter (Q3) of
Home
Page 402
Avenue Therapeutics Announces Pricing of Public Offering, Faces Stock Decline
Avenue Therapeutics, a prominent specialty pharmaceutical company with a primary focus on advancing therapies for neurologic diseases, revealed today the pricing details of its public
Global Leaders Converge in Washington for International Counter Ransomware Summit
Just a day after the Biden administration introduced a comprehensive executive order on artificial intelligence, the White House is now hosting leaders from around the
US Treasury Prepares for Quarterly Refunding Update; Market Anticipates Impact on Bond Supply
On Monday, the US Treasury announced its preparations for a quarterly refunding update scheduled for Wednesday. This pivotal update is set to unveil the extent
Sientra Reports Q3 Revenue Below Estimates; Stock Value Declines
Sientra, a leading Irvine-based manufacturer specializing in implants and related products for breast augmentation and reconstruction surgery, witnessed a decline in its stock value following
Kintara Therapeutics Faces Stock Dip After Disappointing VAL-083 Study Results
In a significant development, Kintara Therapeutics, a prominent biopharmaceutical entity specializing in the advancement of novel solid tumor cancer treatments, witnessed a dip in its
Cardio Diagnostics Secures Innovation Technology Contract with Vizient
Cardio Diagnostics Holdings, a trailblazer in artificial intelligence-powered precision cardiovascular medicine tests, has announced the acquisition of an Innovation Technology contract from Vizient, the nation’s
Avalo Therapeutics Completes Divestiture of 800 Series Assets to AUG Therapeutics
Avalo Therapeutics, a pioneering biotechnology company dedicated to the development of innovative treatments for immunological diseases, announced today the successful completion of the divestiture of
October Sees Eurozone Inflation Weakest Since 2019, ECB Reconsiders Rates
Preliminary data released on Tuesday revealed that Eurozone inflation witnessed a significant dip in October, marking its feeblest rate in over two years. This decline,
Fed’s Policy Decision: US Stocks Tread Cautiously in Anticipation
In a day marked by cautious movements, US stocks treaded carefully on Tuesday, bracing for the impending policy decision from the Federal Reserve. The S&P
